Cargando…

Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer

Detalles Bibliográficos
Autores principales:	Saunders, M P, Valle, J W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376364/ http://dx.doi.org/10.1038/sj.bjc.6600849

Ejemplares similares

New NICE guidance on acne vulgaris: implications for first-line management in primary care
por: Wilcock, Jane, et al.
Publicado: (2021)

Reply 2: NICE guidelines on drugs for colorectal cancer
por: Ross, P J, et al.
Publicado: (2003)

Why hasn't the National Institute been ‘NICE’ to patients with colorectal cancer?
por: Saunders, M P, et al.
Publicado: (2002)

Recent NICE guidance of interest to surgeons
por: Campbell, Bruce
Publicado: (2013)

Examining the implementation of NICE guidance: cross-sectional survey of the use of NICE interventional procedures guidance by NHS Trusts
por: Lowson, Karin, et al.
Publicado: (2015)

NICE family history guidance and implementation update
por: Mackay, J
Publicado: (2006)

Management of rheumatoid arthritis: summary of NICE guidance
por: Deighton, Chris, et al.
Publicado: (2009)

Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
por: Curtis, Helen, et al.
Publicado: (2018)

Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
por: Feliu, J, et al.
Publicado: (2011)

Trends in procedures for infertility and caesarean sections: was NICE disinvestment guidance implemented? NICE recommendation reminders
por: Chamberlain, Charlotte A, et al.
Publicado: (2013)

Intravenous fluid prescribing: Improving prescribing practices and documentation in line with NICE CG174 guidance
por: Sansom, Luke Thomas, et al.
Publicado: (2014)

When to suspect child maltreatment: summary of NICE guidance
por: Saperia, Julia, et al.
Publicado: (2009)

NICE medical technologies guidance: aims for clinical practice
por: Campbell, Bruce
Publicado: (2013)

Gastro-oesophageal reflux disease in children: NICE guidance
por: Davies, Ieuan, et al.
Publicado: (2015)

Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2004)

Diagnosis and treatment of advanced breast cancer: summary of NICE guidance
por: Murray, N, et al.
Publicado: (2009)

Management of generalised anxiety disorder in adults: summary of NICE guidance
por: Kendall, Tim, et al.
Publicado: (2011)

NICE guidance for moderate RA—a step in the right direction
por: The Lancet Rheumatology
Publicado: (2021)

Rising Prevalence of Diabetes Mellitus in Saudi Arabia: Cause for Concern and Call for Urgent Control Program
por: Alnuaim, Abdulrahman
Publicado: (2014)

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2019)

NICE Cancer Guidance: a description of the Institute's Clinical Guideline Programme
por: Littlejohns, P, et al.
Publicado: (2003)

NICE Cancer Guidance: a description of the Institute's Clinical Guideline Programme
por: Littlejohns, P, et al.
Publicado: (2003)

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
por: Sofat, Reecha, et al.
Publicado: (2012)

Intrapartum care of healthy women and their babies: summary of updated NICE guidance
por: Delgado Nunes, Vanessa, et al.
Publicado: (2014)

Adherence to NICE guidance on lifestyle advice for people with schizophrenia: a survey
por: Swaby, Lizzie, et al.
Publicado: (2017)

Use of test accuracy study design labels in NICE’s diagnostic guidance
por: Olsen, M., et al.
Publicado: (2019)

gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance
por: O’Connell, Susan, et al.
Publicado: (2021)

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
por: Sheikh, H Y, et al.
Publicado: (2007)

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
por: Yamamoto, Shun, et al.
Publicado: (2021)

Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer
por: Fisch, Michael J, et al.
Publicado: (2020)

An urgent call to raise the bar in oncology
por: Schnog, John-John B., et al.
Publicado: (2021)

When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?: A Systematic Review of NICE Guidance
por: Longworth, Louise, et al.
Publicado: (2013)

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer
por: Saunders, M P, et al.
Publicado: (2004)

The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology Guidance
por: Cleves, Andrew, et al.
Publicado: (2016)

Capturing what matters: updating NICE methods guidance on measuring and valuing health
por: Dawoud, Dalia, et al.
Publicado: (2022)

Modelling clinical narrative as computable knowledge: The NICE computable implementation guidance project
por: Scott, Philip, et al.
Publicado: (2023)

Safer fluid prescribing at North Bristol Trust: Bringing practice in line with NICE Guidance with a redesign of the fluid prescription chart
por: Andersson, Johanna, et al.
Publicado: (2015)

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients
por: Schirripa, Marta, et al.
Publicado: (2018)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
por: Antoun, Sami, et al.
Publicado: (2019)

Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial
por: Muro, Kei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_upegaep8007u4pujg0s0rioohh